Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-aminoadamantan-1-ol
2. 702-82-9
3. 3-amino-1-hydroxyadamantane
4. 1-amino-3-adamantanol
5. (5r,7s)-3-aminoadamantan-1-ol
6. 3-amino-adamantanol
7. 3-amino-1-adamantanol Hydrate
8. 1-aminoadamantane-3-ol
9. 3-hydroxy-1-aminoadamantane
10. 1-amino-3-hydroxyadamantane
11. Tricyclo[3.3.1.13,7]decan-1-ol, 3-amino-
12. Mfcd01821204
13. Cbdive_015882
14. 3-hydroxyadamantane Amine
15. Oprea1_650197
16. Schembl301876
17. Chembl1624488
18. Dtxsid00349729
19. Albb-014973
20. Stk387549
21. Akos000283819
22. Akos016344511
23. Cs-w016045
24. Pb47584
25. Ps-6215
26. Sdccgmls-0042673.p002
27. Sy003569
28. Db-014233
29. 3-aminotricyclo[3.3.1.13,7]decan-1-ol
30. Am20070529
31. Bb 0261502
32. Ft-0652890
33. 3-aminotricyclo[3.3.1.1~3,7~]decan-1-ol
34. 3-hydroxytricyclo[3.3.1.13,7 ]decan-1-amine
35. Ab00073968-01
36. 3-hydroxytricyclo[3.3.1.13,7 ]decan- 1-amine
37. A836825
38. 3-amino-1-adamantanol; 3-amino-1-hydroxyadamantane
39. Z1741981630
40. Tricyclo[3.3.1.1~3,7~]decan-1-ol, 3-amino-, Hydrochloride
41. N-benzyl-2-(6-morpholin-4-ylpyridin-3-yl)-1,3-thiazole-4-carboxamide
| Molecular Weight | 167.25 g/mol |
|---|---|
| Molecular Formula | C10H17NO |
| XLogP3 | 0.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 167.131014166 g/mol |
| Monoisotopic Mass | 167.131014166 g/mol |
| Topological Polar Surface Area | 46.2 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 212 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
46
PharmaCompass offers a list of 3-Amino-1-Adamantanol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 3-Amino-1-Adamantanol manufacturer or 3-Amino-1-Adamantanol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3-Amino-1-Adamantanol manufacturer or 3-Amino-1-Adamantanol supplier.
PharmaCompass also assists you with knowing the 3-Amino-1-Adamantanol API Price utilized in the formulation of products. 3-Amino-1-Adamantanol API Price is not always fixed or binding as the 3-Amino-1-Adamantanol Price is obtained through a variety of data sources. The 3-Amino-1-Adamantanol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 3-Amino-1-Adamantanol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3-Amino-1-Adamantanol, including repackagers and relabelers. The FDA regulates 3-Amino-1-Adamantanol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3-Amino-1-Adamantanol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3-Amino-1-Adamantanol supplier is an individual or a company that provides 3-Amino-1-Adamantanol active pharmaceutical ingredient (API) or 3-Amino-1-Adamantanol finished formulations upon request. The 3-Amino-1-Adamantanol suppliers may include 3-Amino-1-Adamantanol API manufacturers, exporters, distributors and traders.
3-Amino-1-Adamantanol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3-Amino-1-Adamantanol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3-Amino-1-Adamantanol GMP manufacturer or 3-Amino-1-Adamantanol GMP API supplier for your needs.
A 3-Amino-1-Adamantanol CoA (Certificate of Analysis) is a formal document that attests to 3-Amino-1-Adamantanol's compliance with 3-Amino-1-Adamantanol specifications and serves as a tool for batch-level quality control.
3-Amino-1-Adamantanol CoA mostly includes findings from lab analyses of a specific batch. For each 3-Amino-1-Adamantanol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3-Amino-1-Adamantanol may be tested according to a variety of international standards, such as European Pharmacopoeia (3-Amino-1-Adamantanol EP), 3-Amino-1-Adamantanol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3-Amino-1-Adamantanol USP).
